Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$28.51 - $32.9 $3.41 Million - $3.94 Million
-119,780 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$26.37 - $34.22 $23,706 - $30,763
899 Added 0.76%
119,780 $3.49 Million
Q3 2021

Nov 12, 2021

BUY
$23.54 - $31.39 $10,804 - $14,408
459 Added 0.39%
118,881 $3.17 Million
Q2 2021

Aug 09, 2021

SELL
$26.72 - $33.19 $4,916 - $6,106
-184 Reduced 0.16%
118,422 $3.65 Million
Q1 2021

May 11, 2021

BUY
$24.15 - $31.45 $2.86 Million - $3.73 Million
118,606 New
118,606 $3.11 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.9B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Madison Asset Management, LLC Portfolio

Follow Madison Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Madison Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Madison Asset Management, LLC with notifications on news.